Efficacy and Safety of Paliperidone ER in Patients With First Episode Psychosis: an Open-label, Prospective Multi-center Study.
Phase of Trial: Phase IV
Latest Information Update: 18 Jan 2018
At a glance
- Drugs Paliperidone (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 30 Jul 2015 Status changed from recruiting to completed as per Clinical Trials Register record.
- 10 Feb 2012 Planned End Date changed from 1 Jun 2011 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 25 Aug 2011 New source identified and integrated (Korean Clinical Trials Register record KCT0000009).